KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

KF2023#1-Trial: Influence of Statin Intake on Cellular Readouts — Stella

Recruiting

Back to Pharmacodynamics trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Finland

Department of Clinical Pharmacology, Helsinki

Key details

Phase

Early testing

Sponsor

Mikko Niemi

Collaborators

University of Helsinki

Enrollment target

~15 participants

Started

April 2024

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 40 Years

Last updated June 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov